India's top General Medicine centres offer world-class Leukemia Chronic Lymphocytic Cll with proven surgical approaches and cutting-edge technology — at 60-80% lower cost than USA/UK. Our JCI/NABH-accredited partner hospitals deliver outstanding outcomes with internationally trained specialists.
Chronic lymphocytic leukemia (CLL) is a cancer of the lymphocytes, a type of white blood cell involved in the body’s immune system. Lymphocytes are normally found in the blood, lymph nodes, bone marrow (the spongy, red tissue in the inner part of the large bones), spleen, and in a clear fluid called lymph that flows through small vessels in the body and collects in lymph nodes.
There are two general types of CLL, and it is important for doctors to assess whether the disease is caused by the overgrowth of T cells or B cells. T cells and B cells are specific types of lymphocytes. T cells normally help to fight infections by activating other cells in the immune system, while B cells are part of the antibody-producing machinery of the immune system. The T-cell type of CLL is less common (about 1% of all CLL cases) and progresses more rapidly than the B-cell type of the disease (more than 95% of all CLL cases).
A risk factor is anything that increases a person's chance of developing cancer. Some risk factors can be controlled, such as smoking, and some cannot be controlled, such as age and family history. Although risk factors can influence the development of cancer, most do not directly cause cancer. Some people with several risk factors never develop cancer, while others with no known risk factors do. However, knowing your risk factors and communicating them to your doctor may help you make more informed lifestyle and health-care choices.
The cause of CLL is unknown. There is no proven link that exposure to radiation, chemicals, or chemotherapy increases a person's risk of developing CLL. The following factors may raise a person's risk of developing CLL:
Family history. Approximately 20% of patients with CLL have a relative with CLL or some other lymph-related cancer. In order to learn more about the familial pattern that occurs in some patients, a registry of such families has been established at the National Cancer Institute.
Age. CLL is most common in older adults, is rare in young adults, and virtually never occurs in children. About 90% of people diagnosed with leukemia are over age 50.
Gender. CLL occurs more frequently in men.
Recognising these signs early can help you seek timely treatment and achieve the best possible outcomes.
A new lump, growth or swelling that is painless, firm, and growing — the most common early sign of cancer that requires immediate biopsy.
Losing more than 5 kg without trying — a systemic sign of cancer that affects the body's metabolism and nutritional status.
Extreme tiredness unrelated to activity or sleep — caused by cancer cells consuming the body's energy resources and bone marrow infiltration.
Yellowing of skin/eyes (jaundice), blood in urine or stool, change in bowel habits persisting more than 4 weeks — potential signs of GI or GU malignancy.
Drenching night sweats, persistent low-grade fever, and recurring infections — classic 'B symptoms' of lymphoma and haematological cancers.
Raised tumour markers (PSA, CEA, CA-125, AFP), abnormal lymph nodes on CT/PET-CT, or suspicious finding on MRI requiring oncology evaluation.
India ranks among the top 5 global destinations for medical tourism
40+ JCI-accredited hospitals across major cities
Over 500,000 international patients treated annually
Average savings of 70-80% on treatment costs
India has become a preferred destination for international patients seeking Leukemia, Chronic Lymphocytic (CLL) treatment. With over 500,000 medical tourists annually, India's healthcare infrastructure is well-equipped to handle complex cases with outcomes comparable to Western countries.
The key advantage of seeking Leukemia, Chronic Lymphocytic (CLL) treatment in India is the combination of world-class medical expertise and significant cost savings. Patients save 60-85% while receiving care at hospitals that meet the same accreditation standards as top US and UK institutions.
Our partner hospitals offer multiple evidence-based treatment approaches. Your specialist will recommend the most appropriate option.
Thorough diagnostic workup using advanced imaging and laboratory investigations to accurately assess Leukemia, Chronic Lymphocytic (CLL) and plan optimal treatment.
Evidence-based non-surgical approaches that may be appropriate as first-line treatment depending on the severity of Leukemia, Chronic Lymphocytic (CLL).
State-of-the-art surgical treatment for Leukemia, Chronic Lymphocytic (CLL) performed by fellowship-trained specialists using the latest technology and minimally invasive techniques where possible.
Comprehensive recovery programme including physiotherapy, pain management, and long-term follow-up to ensure optimal outcomes.
India offers world-class care at a fraction of the cost. All costs below are approximate and vary by hospital and case complexity.
| Procedure | India (USD) | USA / UK | Savings |
|---|---|---|---|
| Leukemia Chronic Lymphocytic Cll (Standard) | $5,000-12,000 | $30,000-60,000 | Save 70-80% |
| Leukemia Chronic Lymphocytic Cll (Complex) | $10,000-20,000 | $50,000-100,000 | Save 75-85% |
| Pre-op Tests & Evaluation | $200-500 | $2,000-5,000 | Save 80-90% |
India's top hospitals meet the same quality standards as US and European hospitals.
Fellowship-trained specialists with decades of experience and international training.
Same quality treatment at a fraction of Western prices, saving tens of thousands of dollars.
Treatment begins within days, not months. Priority scheduling for international patients.
Visa assistance, airport transfers, accommodation, and dedicated patient coordinator.
All consultations and reports in English. Arabic, French, and Russian interpreters available.
"The treatment I received in India was outstanding. The doctors were highly experienced and the hospital facilities were world-class. I saved over 70% compared to my home country."
"Indian Med Guru coordinated everything perfectly - from visa to hospital to recovery. The quality of care was exceptional and the cost was a fraction of what I was quoted in the UK."
"My family member received excellent treatment. The coordinator guided us through every step. We are grateful for the care and attention we received throughout our stay in India."
Share your medical reports with our team. A specialist will review your case and provide a personalised treatment recommendation - completely free, within 24 hours.
Everything you need to know about Leukemia Chronic Lymphocytic Cll treatment in India.
Send your medical reports now and receive a free personalised treatment plan from India's leading specialists within 24 hours.
Disclaimer: The information provided on this page is intended for general educational purposes only and does not constitute medical advice, diagnosis, or treatment.